In addition to these findings, a contrary role of PARP inhibitors has been reported in AML (acute myeloid leukemia)/MDS (myelodysplastic syndrome) conditions as microsatellite instability was linked to the reduced expression of HR repair genes (Kontandreopoulou et al., 2021). Here, PARP1 is linked to myelodysplastic syndrome.